论文部分内容阅读
1994年 12月 ,按照中国预科院流研所《流行性出血热疫苗效果评价及免疫策略研究现场实施方案》的要求 ,我县选择了长春生物制品研究所生产的Ⅱ型肾综合征出血热 (ＨＦＲＳ)地鼠肾单价灭活疫苗完成了人群试点接种和 4个流行年度的对照观察。接种组 775 3人未发生 1例ＨＦＲＳ病
In December 1994, according to the requirements of the “Implementation Plan of Epidemic Haemorrhagic Fever Vaccine Evaluation and Immunization Strategy Research Site” of the Institute of Flowing Research at China Preparatory School, the county selected the hemorrhagic fever with type Ⅱ renal syndrome (Ⅱ) produced by Changchun Institute of Biological Products HFRS) hamster kidney monovalent inactivated vaccine completed the pilot population in the population and a controlled observation of 4 prevalence years. Vaccination group 775 3 cases did not occur HFRS disease